If the medication were injected into a muscle (intramuscular) or a vein (intravenous), the absorption rate would change drastically, potentially leading to a spike in side effects or a shorter duration of action
Phase 2 trial data (NCT04881760) reported diarrhoea in approximately 2030% of participants at higher doses, with symptoms most pronounced during dose-escalation phases
Phase 3 trials are currently underway and expected to conclude by 2025-2026 Regulatory review processes add 12-18 months after trial completion UK availability is realistically expected around 2026-2027 at earliest NHS access would require NICE approval following MHRA licensing Private prescription availability may precede NHS access Preparing for Future Treatment Options While waiting for Retatrutide to become available, there are meaningful steps you can take to prepare for future weight management treatments and improve your health in the meantime
Effects of SGLT2 Inhibitors on Renin-Aldosterone System for One Month and Six Months in Type 2 Diabetes
Fortunately, Vitamin B12 Injections offer a proven solution to counter these effects, rejuvenating your vitality and ensuring you look, feel, and perform at your very best
Medical risks: pancreatitis history, kidney disease, pregnancy plans, or eating disorder history
